Genscript Biotech Corporation (HKG:1548)
Hong Kong
· Delayed Price · Currency is HKD 13.62
+0.09 (0.67%)
Apr 29, 2026, 4:08 PM HKT
Genscript Biotech Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 29,605 | 27,155 | 21,097 | 42,166 | 52,563 | 72,496 | Upgrade
|
| Market Cap Growth | 12.35% | 28.72% | -49.97% | -19.78% | -27.50% | 229.03% | Upgrade
|
| Enterprise Value | 26,008 | 24,137 | 18,906 | 38,022 | 47,670 | 64,744 | Upgrade
|
| Last Close Price | 13.53 | 12.42 | 9.84 | 19.86 | 24.85 | 34.50 | Upgrade
|
| PE Ratio | - | - | 0.92 | - | - | - | Upgrade
|
| Forward PE | 43.44 | 41.99 | - | - | - | - | Upgrade
|
| PS Ratio | 3.96 | 3.64 | 4.57 | 9.63 | 10.77 | 18.97 | Upgrade
|
| PB Ratio | 0.96 | 0.88 | 0.63 | 2.64 | 4.95 | 6.70 | Upgrade
|
| P/TBV Ratio | 0.96 | 0.88 | 0.63 | 3.94 | 6.85 | 9.25 | Upgrade
|
| P/FCF Ratio | 15.63 | 14.33 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 11.68 | 10.72 | 35.90 | - | - | - | Upgrade
|
| PEG Ratio | - | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | Upgrade
|
| EV/Sales Ratio | 3.48 | 3.23 | 4.09 | 8.68 | 9.77 | 16.94 | Upgrade
|
| EV/EBITDA Ratio | - | 9.76 | 34.75 | 58.29 | - | - | Upgrade
|
| EV/EBIT Ratio | - | 12.15 | 262.23 | 185.81 | - | - | Upgrade
|
| EV/FCF Ratio | 13.73 | 12.74 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.06 | 0.41 | 0.48 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 1.05 | 1.05 | 2.94 | 8.59 | - | - | Upgrade
|
| Debt / FCF Ratio | 1.42 | 1.42 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.12 | -0.09 | -0.53 | -0.59 | -0.71 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.47 | -1.47 | -5.30 | -13.00 | 2.08 | 2.89 | Upgrade
|
| Net Debt / FCF Ratio | -1.92 | -1.92 | 3.09 | 2.01 | 2.40 | 3.66 | Upgrade
|
| Asset Turnover | 0.19 | 0.19 | 0.14 | 0.19 | 0.26 | 0.27 | Upgrade
|
| Inventory Turnover | 11.50 | 11.50 | 7.64 | 5.12 | 6.17 | 5.46 | Upgrade
|
| Quick Ratio | 1.35 | 1.35 | 0.97 | 4.50 | 2.99 | 3.80 | Upgrade
|
| Current Ratio | 1.50 | 1.50 | 1.07 | 4.76 | 3.23 | 3.97 | Upgrade
|
| Return on Equity (ROE) | -12.85% | -12.85% | -5.46% | 9.56% | -31.12% | -47.05% | Upgrade
|
| Return on Assets (ROA) | 3.15% | 3.15% | 0.13% | 0.55% | -11.45% | -12.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.30% | 6.85% | 0.38% | 3.34% | -91.80% | -152.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.20% | 6.20% | 0.20% | 0.90% | -21.90% | -20.80% | Upgrade
|
| Earnings Yield | -14.01% | -15.27% | 109.05% | -1.77% | -3.36% | -3.86% | Upgrade
|
| FCF Yield | 6.40% | 6.98% | -4.42% | -9.99% | -4.99% | -2.90% | Upgrade
|
| Buyback Yield / Dilution | -0.63% | -0.63% | -3.27% | -0.58% | -3.28% | -6.83% | Upgrade
|
| Total Shareholder Return | -0.63% | -0.63% | -3.27% | -0.58% | -3.28% | -6.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.